TME Steering Committee

Theresa A. Guise, MD
(2020-2021)Professor, Endocrine Neoplasia & HD
University of Texas MD Anderson Cancer Center
Houston, Texas

Mikala Egeblad, PhD
(2020-2021)Associate Professor
Cold Spring Harbor Laboratory
Cold Spring Harbor, New York

Sheila A. Stewart, DPhil
(2020-2021)Professor, Division of Cell Biology and Physiology
Washington University in St. Louis
St. Louis, Missouri

Sergei I. Grivennikov, PhD
(2020-2022)Associate Professor
Fox Chase Cancer Center
Cancer Prevention and Control
Philadelphia, Pennsylvania

Xin Lu, PhD
(2019-2021)John M. and Mary Jo Boler Assistant Professor
University of Notre Dame, Department of Biological Sciences, Center for Rare & Neglected Diseases, Harper Cancer Research Institute
Notre Dame, Indiana

Ilaria Malanchi, PhD
(2020-2022)Senior Group Leader
The Francis Crick Institute
London, United Kingdom

Jeffrey W. Pollard, PhD
(2019-2021)Director, MRC Centre for Reproductive Health
University of Edinburgh, The Queen’s Medical Research Institute
Edinburgh, United Kingdom

Ashani T. Weeraratna, PhD
(2020-2022)E.V. McCollum Chair of Biochemistry and Molecular Biology
Bloomberg Distinguished Professor of Cancer Biology
Co-Program Leader, Cancer Invasion and Metastasis, Sidney Kimmel Cancer Center
Johns Hopkins School of Medicine
Baltimore, Maryland

Alana L. Welm, PhD
(2019-2021)Ralph E. and Willia T. Main Presidential Endowed Chair in Cancer Research; Co-Director, Cell Response & Regulation Program Investigator; Associate Professor, Oncological Sciences
University of Utah, Huntsman Cancer Institute
Salt Lake City, Utah

Yves A. DeClerck, MD
(2019-2021)Professor of Pediatrics, Biochemistry & Molecular Medicine
USC/Children’s Hospital of Los Angeles
Los Angeles, California

Julio A. Aguirre-Ghiso, PhD
(2020-2022)Professor, Division of Hematology and Oncology
Tisch Cancer Institute at Mount Sinai
Director, Head and Neck Cancer Basic Research
Icahn School of Medicine at Mount Sinai
New York, New York